Print-friendly View
Resources for Health Professionals and Patients
| Review: Three- vs Four-Drug Antiretroviral Regimens for the Initial Treatment of HIV-1 Infection : a randomized controlled trial. | |
Attached file: |
(Russian, 426.9 kb)
Review: Three- vs Four-Drug Antiretroviral Regimens for the Initial Treatment of HIV-1 Infection : a randomized controlled trial.
|
Link to document(s) | http://www.ncbi.nlm.nih.gov... |
Author(s): | Gulick R. et al. |
Document type: | Literature Reviews |
Language: | English, Russian |
Original language of document: | Russian |
Primary area(s) of focus: | HIV/AIDS |
Secondary areas of focus: | Client advocacy - human rights protection and legal support, Food security / support |
Submited by: | Victor Stanilevskiy |
Material written specifically for patients: | No |
Date of entry: | September 13, 2006 |
Pages: | 3 |
| Three-drug antiretroviral regimens are standard of care for initial treatment of human immunodeficiency virus 1 (HIV-1) infection, but a 4-drug regimen could improve antiretroviral activity and be more effective than a 3-drug regimen. | |
Overall user rating: | Not yet reviewed |
